Abstract
This multicenter retrospective study aimed to evaluate the association between the coefficient of variation (CV) of serum albumin during the first year of peritoneal dialysis (PD) and clinical outcomes, including technique failure and all-cause mortality. We enrolled patients who initiated PD between January 1, 2018 and December 31, 2024 from three medical centers and maintained treatment for over one year. The albumin-CV was calculated from serial serum albumin measurements during the first year. Participants were categorized into low-, medium-, and high-variability groups based on albumin-CV tertiles. Primary endpoints were technique failure and all-cause mortality. Survival analyses were performed using Kaplan–Meier curves with log-rank tests. Multivariable Cox regression models were employed to assess independent associations. Among 759 included patients (mean age 57.81 ± 13.28 years; 58.8% male), 15.9% had diabetic nephropathy. After a median follow-up of 37 months, 66 technique failures and 170 all-cause deaths occurred. The high-albumin-variability group showed higher prevalence of diabetes and lower hemoglobin, albumin, calcium, and phosphorus levels (all p < 0.05). Albumin variability was significantly associated with all-cause mortality (log-rank χ2 = 8.017, p = 0.013) but not with technique failure. After adjusting for confounders, albumin-CV remained an independent predictor of all-cause mortality (HR = 1.039, 95% CI 1.014–1.064, p = 0.002). Higher variability in serum albumin during the first year of PD is independently associated with increased risk of all-cause mortality.
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Bello, A. K. et al. An update on the global disparities in kidney disease burden and care across world countries and regions. Lancet Glob Health. 12 (3), e382–e395. https://doi.org/10.1016/S2214-109X(23)00570-3 (2024).
Guo, S. et al. Risk factors of different mortality periods in older patients with end-stage renal disease undergoing urgent-start peritoneal dialysis: a retrospective observational study. BMC Geriatr. 24 (1), 343. https://doi.org/10.1186/s12877-024-04931-4 (2024).
Liu, X. et al. Patient characteristics and risk factors of early and late death in incident peritoneal dialysis patients. Sci. Rep. 6, 32359. https://doi.org/10.1038/srep32359 (2016).
Lin, T. Y. et al. Malnutrition is Associated with Increased Morbidity and Death in Dialysis Patients Undergoing Endovascular Therapy for Peripheral Artery Disease. Eur. J. Vasc Endovasc Surg. 64 (2–3), 225–233. https://doi.org/10.1016/j.ejvs.2022.03.045 (2022).
Jin, L. et al. Serum albumin at 1 year after peritoneal dialysis predicts long-term outcomes on continuous ambulatory peritoneal dialysis. Ren. Fail. 44 (1), 252–257. https://doi.org/10.1080/0886022X.2022.2033264 (2022).
Wang, X. et al. Serum albumin changes and mortality risk of peritoneal dialysis patients. Int. Urol. Nephrol. 52 (3), 565–571. https://doi.org/10.1007/s11255-020-02389-y (2020).
Li, J. et al. Dynamic changes in serum albumin and ferritin indicate higher risk of early-onset peritonitis in peritoneal dialysis patients. Ther. Apher Dial. https://doi.org/10.1111/1744-9987.14244 (2025).
Li, M. L. et al. Characteristics of registered research in peritoneal dialysis: Past and present. Clin. Nephrol. 101 (1), 17–24. https://doi.org/10.5414/CN111162 (2024).
Li, P. K. et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat. Rev. Nephrol. 13 (2), 90–103. https://doi.org/10.1038/nrneph.2016.181 (2017).
See, E. J. et al. Risk Predictors and Causes of Technique Failure Within the First Year of Peritoneal Dialysis: An Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Study. Am. J. Kidney Dis. 72 (2), 188–197. https://doi.org/10.1053/j.ajkd.2017.10.019 (2018).
Cho, Y. et al. Early Peritoneal Dialysis Technique Failure: Review. Perit. Dial Int. 38 (5), 319–327. https://doi.org/10.3747/pdi.2018.00017 (2018).
Chen, C. et al. Impact of serum albumin level and variability on short-term cardiovascular-related and all-cause mortality in patients on maintenance hemodialysis. Med. (Baltim). 100 (43), e27666. https://doi.org/10.1097/MD.0000000000027666 (2021).
Song, P. et al. Dynamic serum albumin and outcome of peritoneal dialysis patients: A retrospective study in China. Front. Med. (Lausanne). 9, 917603. https://doi.org/10.3389/fmed.2022.917603 (2022).
Chiu, P. F. et al. Trajectories of Serum Albumin Predict Survival of Peritoneal Dialysis Patients: A 15-year Follow-Up Study. Med. (Baltim). 95 (12), e3202. https://doi.org/10.1097/MD.0000000000003202 (2016).
Malho, G. A. et al. Peritoneal Protein Loss, Inflammation, and Nutrition: Refuting Myths. Front. Med. (Lausanne). 9, 884061. https://doi.org/10.3389/fmed.2022.884061 (2022).
Huang, Y. T., Jiang, M. Y. & Hwang, J. C. Albumin to prealbumin ratio in peritoneal dialysis patients: Clinical implication and outcome prediction. PLoS One. 17 (11), e276159. https://doi.org/10.1371/journal.pone.0276159 (2022).
Liu, Y. et al. Associations between neutrophil-percentage-to-albumin ratio level and all-cause mortality and cardiovascular disease-cause mortality in general population: evidence from NHANES 1999–2010. Front. Cardiovasc. Med. 11, 1393513. https://doi.org/10.3389/fcvm.2024.1393513 (2024).
Castillo, J. C. et al. Variations in Serum Albumin Levels Over Time in Patients Treated With Conventional Hemodialysis or Expanded Hemodialysis: A Cohort Study. Hemodial. Int. 29 (3), 327–334. https://doi.org/10.1111/hdi.13232 (2025).
Ma, X. et al. Analysis of risk factors and outcome in peritoneal dialysis patients with early-onset peritonitis: a multicentre, retrospective cohort study. BMJ Open. 10 (2), e29949. https://doi.org/10.1136/bmjopen-2019-029949 (2020).
Xu, M. et al. The neutrophil percentage-to-albumin ratio is an independent risk factor for poor prognosis in peritoneal dialysis patients. Ren. Fail. 46 (1), 2294149. https://doi.org/10.1080/0886022X.2023.2294149 (2024).
Ma, H. et al. Platelet-to-albumin ratio: a potential biomarker for predicting all-cause and cardiovascular mortality in patients undergoing peritoneal dialysis. BMC Nephrol. 25 (1), 365. https://doi.org/10.1186/s12882-024-03792-8 (2024).
Guo, X. et al. The prognostic role of hemoglobin, albumin, lymphocyte, and platelets score in peritoneal dialysis. Int. Urol. Nephrol. https://doi.org/10.1007/s11255-025-04679-9 (2025).
Salani, M. Strategies to Reduce Technique Failure in Peritoneal Dialysis. Kidney360 6 (4), 496–497. https://doi.org/10.34067/KID.0000000778 (2025).
Xie, W. et al. Clinical risk factors for peritoneal dialysis withdrawal at different dialysis duration. Ren. Fail. 45 (2), 2274965. https://doi.org/10.1080/0886022X.2023.2274965 (2023).
Khan, S. F. Updates on Infectious and Other Complications in Peritoneal Dialysis: Core Curriculum 2023. Am. J. Kidney Dis. 82 (4), 481–490. https://doi.org/10.1053/j.ajkd.2023.03.011 (2023).
Zhang, J. et al. Risk factors for mortality in patients undergoing peritoneal dialysis: a systematic review and meta-analysis. Ren. Fail. 43 (1), 743–753. https://doi.org/10.1080/0886022X.2021.1918558 (2021).
Lai, K. J. et al. Association of albumin and globulin with mortality risk in incident peritoneal dialysis patients. Nutrients 14 (14). https://doi.org/10.3390/nu14142850 (2022).
Zoccali, C. et al. Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association. Cardiovasc. Res. 119 (11), 2017–2032. https://doi.org/10.1093/cvr/cvad083 (2023).
Acknowledgements
We would like to extend our sincere gratitude to all team members for their diligent efforts in this study.
Author information
Authors and Affiliations
Contributions
Y. M. and L. C. designed the study, W.Q , S.F, and S.W. extracted and collated the data, Y. M. , H.L. and J.N. performed the analyses. Y. M. wrote the manuscript. W.C. , X.J. ,Y. Z. and F. X. reviewed and edited the manuscript. The manuscript has been approved by all the authors and is ready for publication.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Min, Y., Cheng, L., Liu, H. et al. Impact of albumin variability during the first year on prognosis in peritoneal dialysis patients. Sci Rep (2026). https://doi.org/10.1038/s41598-026-47169-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-47169-3
